The ambition of the T2EVOLVE Association is to ignite the transformation of engineered T-cell therapy into an accessible, scalable, reliable, and socioeconomically desirable treatment modality in cancer medicine. The interdisciplinary T2EVOLVE association is made up of 28 European founding members from 9 nations across Europe. Partners include university and non-university research facilities, pharmaceutical, and biotechnology companies, as well as regulatory authorities. Something new is coming to Europe’s cell therapy landscape. A permanent home for collaboration, innovation, and collective impact. This teaser marks the beginning of the journey toward the official opening of the T2EVOLVE Association, a new chapter built on the foundations of the T2EVOLVE IMI project and powered by Europe’s leading experts. The future is evolving. Are you ready?
| Website | https://t2evolve.com |
| Employees | 3 (0 on RocketReach) |
| Industry | Public Health |
| Keywords | Translational Research, Cancer Research, Cancer Treatment, Cell Therapy, Advanced Therapies, Cancer Immunotherapy, Immunotherapy Research, Oncology, Biotechnology, Pharmaceutical Research, Healthcare, Drug Development, Medical Research, Clinical Trials, Precision Medicine, Therapeutic Innovation, Biopharmaceutical, Life Sciences |
Looking for a particular T2EVOLVE employee's phone or email?
T2EVOLVE Questions
Related Companies
